1 week Ago By Defense World Staff
Geode Capital Management LLC grew its stake in shares of Definitive Healthcare Corp. (NASDAQ:DH – Free Report) by 3.2% in the fourth quarter, according to the company in its most recent filing with the SEC.
The firm owned 1,272,660 shares of the company’s stock after acquiring an additional 39,938 shares during the quarter. Geode Capital Management LLC owned about 1.10% of Definitive Healthcare worth $5,231,000 as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. Principal Financial Group Inc. boosted its holdings in shares of Definitive Healthcare by 9.
7% in the 4th quarter. Principal Financial Group Inc. now owns 43,960 shares of the company’s stock valued at $181,000 after purchasing an additional 3,874 shares in the last quarter.
Rhumbline Advisers boosted its stake in Definitive Healthcare by 5.2% in the fourth quarter. Rhumbline Advisers now owns 81,316 shares of the company’s stock valued at $334,000 after buying an additional 4,034 shares in the last quarter.
Nisa Investment Advisors LLC grew its position in Definitive Healthcare by 3,652.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 6,980 shares of the company’s stock valued at $29,000 after acquiring an additional 6,794 shares during the last quarter.
SG Americas Securities LLC raised its stake in Definitive Healthcare by 44.6% during the fourth quarter. SG Americas Securities LLC now owns 27,189 shares of the company’s stock worth $112,000 after acquiring an additional 8,387 shares in the last quarter.
Finally, Ieq Capital LLC bought a new position in shares of Definitive Healthcare in the fourth quarter worth about $51,000. 98.67% of the stock is owned by institutional investors and hedge funds.
Definitive Healthcare Price PerformanceShares of DH opened at $2.71 on Friday. The business has a 50-day moving average of $3.
02 and a 200-day moving average of $3.98. The company has a debt-to-equity ratio of 0.
33, a current ratio of 2.49 and a quick ratio of 2.49.
The company has a market capitalization of $305.99 million, a price-to-earnings ratio of -0.87, a price-to-earnings-growth ratio of 4.
06 and a beta of 1.48. Definitive Healthcare Corp.
has a 1 year low of $2.15 and a 1 year high of $7.47.
Definitive Healthcare (NASDAQ:DH – Get Free Report) last released its quarterly earnings results on Thursday, February 27th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.
07 by ($0.04). Definitive Healthcare had a positive return on equity of 1.
76% and a negative net margin of 142.38%. The firm had revenue of $62.
29 million for the quarter, compared to the consensus estimate of $60.60 million. As a group, equities research analysts anticipate that Definitive Healthcare Corp.
will post 0.16 earnings per share for the current year. Analysts Set New Price TargetsSeveral equities research analysts recently issued reports on the stock.
Needham & Company LLC reaffirmed a “hold” rating on shares of Definitive Healthcare in a report on Thursday, January 16th. The Goldman Sachs Group lowered their price target on shares of Definitive Healthcare from $4.50 to $3.
00 and set a “neutral” rating for the company in a report on Tuesday, March 4th. Finally, Barclays cut their price objective on Definitive Healthcare from $4.00 to $3.
00 and set an “underweight” rating on the stock in a report on Monday, March 3rd. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the stock. According to MarketBeat.
com, the stock has an average rating of “Hold” and a consensus target price of $5.35.Check Out Our Latest Stock Analysis on DHDefinitive Healthcare Profile (Free Report)Definitive Healthcare Corp.
, together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.Recommended StoriesFive stocks we like better than Definitive HealthcareThere Are Different Types of Stock To Invest InMarkets Think Robinhood Earnings Could Send the Stock UpWhat Are Treasury Bonds?Churchill Downs Stock: Could Tariff Fears Dampen Derby Gains?Stock Splits, Do They Really Impact Investors?AT&T: Subscriber Growth & Buybacks Signal Bullish Turnaround.
